Blood Biomarkers Predict Vaccine Responses

Pre-existing antibody patterns in human blood can predict how strongly an individual's immune system will respond to a COVID-19 vaccine before they receive the shot. Researchers led by Arizona State University analyzed 8,687 blood samples from 4,089 participants, identifying sentinel antibodies against microbes like Staphylococcus aureus and RSV that correlate with stronger vaccine responses. The study published on August 20, 2026, in Cell Press Blue utilized a deep-learning artificial intelligence model to examine antibody fingerprints across 185 antigens. This approach successfully distinguished strong vaccine responders from weak ones, capturing predictive immune readiness differences that broad demographic or health categories miss. While health conditions like immunosuppression generally raise the risk of weaker responses, broad categories do not tell the whole story since some immunosuppressed participants responded strongly while 5% to 6% of healthy participants had weak responses. Sentinel antibody profiling provides a practical tool that may be easier to adapt for clinical use than genetic analysis. If validated through further studies with other vaccines, this AI-driven blood analysis could guide vaccine development and clinical care. Doctors might eventually use sentinel antibody profiling to identify patients who need additional vaccine doses, closer follow-up, or specialized protective measures.